Minnesota HF4577 establishes a psilocybin therapeutic use program for individuals with qualifying medical conditions, including post-traumatic stress.
Minnesota HF4577 establishes a regulated framework for the therapeutic use of psilocybin by individuals aged 21 and older with qualifying medical conditions. The bill mandates the commissioner of health to administer the program, which includes establishing rules for eligibility, registration, and the operation of treatment centers. It also sets up protections for registered patients, suppliers, facilitators, and health care practitioners, and outlines civil and criminal penalties for violations.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.